Latest Mergers And Acquisitions News

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Cooper Metals Limited is gearing up for significant drilling programs across its Queensland and Western Australia projects, supported by a robust cash position and favourable copper-gold market dynamics.

Kula Gold Limited shares have been suspended following Forrestania Resources’ compulsory acquisition, with delisting scheduled for early February 2026.

Wellnex Life reports a significant turnaround with a 31.5% revenue increase and near break-even operating cash flow in the December quarter, driven by strategic brand consolidation and cost discipline.

Aeris Resources delivered steady copper and gold output in Q2 FY26, achieving a debt-free balance sheet and a robust cash position. Exploration drilling at Tritton signals promising resource extensions.

Premier1 Lithium Limited has completed the full acquisition of the Yalgoo Gold Project in Western Australia, consolidating its position in a highly prospective gold belt and preparing for an aggressive exploration campaign in 2026.

Comet Ridge is set to consolidate 100% ownership of the Mahalo Gas Project, securing key environmental approvals and advancing engineering design and funding efforts to boost east coast gas supply.

Elixinol Wellness Ltd reported a 9.5% revenue increase in Q4 FY25 alongside a 30% cut in operating costs, achieving its first underlying operating cash flow positive quarter. The company’s strategic acquisitions and e-commerce growth underpin a clear path to profitability.

Syntara Limited has made significant strides in its clinical pipeline, launching new trials and receiving key regulatory designations, positioning 2026 as a pivotal year for the company.

Aerometrex Limited has reported record first half revenue and EBITDA for the six months ending December 2025, driven by strong MetroMap subscription growth and a rebound in LiDAR sales.

Starpharma reports strong progress in strategic collaborations and internal drug development, alongside a 70% surge in Viraleze™ online sales and a solid $18.2 million cash position.

Brazilian Rare Earths Limited (BRE) reports a robust scoping study for its Amargosa Bauxite-Gallium Project, alongside a strategic heavy rare earths partnership and a strong cash position to accelerate development.